Nascent RNA interaction keeps PRC2 activity poised and in check

  1. Danny Reinberg1,2
  1. 1Howard Hughes Medical Institute,
  2. 2Department of Biochemistry and Molecular Pharmacology, New York University Langone School of Medicine, New York 10016, USA;
  3. 3Department of Cell and Developmental Biology, Epigenetics Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA;
  4. 4Center for Health Informatics and Bioinformatics, Department of Biochemistry and Molecular Pharmacology, New York University Langone School of Medicine, New York, 10016, USA
  1. Corresponding author: danny.reinberg{at}nyumc.org
  1. 5 These authors contributed equally to this work.

Abstract

Polycomb-repressive complex 2 (PRC2) facilitates the maintenance and inheritance of chromatin domains repressive to transcription through catalysis of methylation of histone H3 at Lys27 (H3K27me2/3). However, through its EZH2 subunit, PRC2 also binds to nascent transcripts from active genes that are devoid of H3K27me2/3 in embryonic stem cells. Here, biochemical analyses indicated that RNA interaction inhibits SET domain-containing proteins, such as PRC2, nonspecifically in vitro. However, CRISPR-mediated truncation of a PRC2-interacting nascent RNA rescued PRC2-mediated deposition of H3K27me2/3. That PRC2 activity is inhibited by interactions with nascent transcripts supports a model in which PRC2 can only mark for repression those genes silenced by transcriptional repressors.

Keywords

Footnotes

  • Received June 25, 2014.
  • Accepted August 13, 2014.

This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

| Table of Contents

Life Science Alliance